March 19, 2019 -- WALMART GLUCODOWN® Sales Increase 27% YTD

BENTONVILLE AR – New sales statistics show GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC) (“Company”), is benefiting from increasing consumer awareness, early in 2019. Sales of GLUCODOWN® at Walmart pharmacies are up 27% for the first seven weeks of 2019 vs. the first seven weeks of 2018. Even more impressive is the 27% sales increase in 2019 is measured against a Walmart price “Rollback” in the same period of 2018 (which began the liquidation of the first generation of GLUCODOWN®).  Glucose Health, Inc. expects Walmart sales of GLUCODOWN® to continue to increase for the balance fiscal 2019 and additionally, to expand distribution to new national and/or large regional drug store chains.
Amazon sales of GLUCODOWN®, which launched in the third quarter of 2018, are also achieving impressive results. GLUCODOWN® Raspberry earned the status of an “Amazon No. 1 New Product Release” – and not only for the diabetic iced tea category – but an “Amazon No. 1 New Product Release” for the entire iced tea category encompassing bottled diabetic, diet and regular sugared iced teas. The Company will provide the latest statistics related to online sales performance on Amazon, next Tuesday, March 22.
Growing Amazon sales are being driven in part, by the newly produced GLUCODOWN® TV commercial, “Available on Amazon,” now airing on Hallmark Movies & Mysteries and Game Show Network.  Viewers of the TV commercial are directed to purchase GLUCODOWN® at a dedicated web domain and storefront ( provided by Amazon for GLUCODOWN®. In order for GLUCODOWN® to qualify for this dedicated web domain and storefront, the Company was required to provide the Amazon Brand Registry with a United States Patent and Trade Office (“USPTO”) principal register trademark. Following  nearly a year of review, Glucose Health, Inc. was recently awarded the highest level of protection from the USPTO, with registration of the trademark “GLUCODOWN®” on the principal register (Reg. # 5572054).  
Glucose Health, Inc. also continues to benefit from its key supplier relationship with Archer Daniels Midland (“ADM”). Last week, Glucose Health, Inc. confirmed the Food and Drug Administration’s acceptance of the clinical research prepared by ADM, supporting the efficacy of the soluble dietary fiber in GLUCODOWN®; which included clinical data related to glucose metabolism and digestive health.  GLUCODOWN® is the first powdered tea mix ever to be successfully enriched with this FDA recognized1 form of soluble dietary fiber.
About Glucose Health, Inc. (OTC: GLUC)
Manufactured by Glucose Health, Inc. (OTC: “GLUC”), GLUCODOWN® is the premier functional tea beverage in the diabetic nutritional consumer category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.2 GLUCODOWN® is a unique and compelling functional beverage and the first tea mix enriched with healthy soluble fiber.  Glucose Health, Inc. is a publicly-traded company with the ticker symbol (OTC: GLUC). GLUCODOWN® is proudly manufactured in the USA in Arkansas and Minnesota.
2National Diabetes Statistics Review, 2017; Centers for Disease Control and Prevention, Department of Health and Human Services.